PCH
BPMC
Polar Capital Holdings’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-541,379
| Closed | -$47.9M | – | 272 |
|
|
2025
Q1 | $47.9M | Sell |
541,379
-85,000
| -14% | -$7.52M | 0.29% | 97 |
|
|
2024
Q4 | $54.6M | Sell |
626,379
-250,626
| -29% | -$21.9M | 0.31% | 86 |
|
|
2024
Q3 | $81.1M | Buy |
877,005
+2,005
| +0.2% | +$185K | 0.39% | 59 |
|
|
2024
Q2 | $94.3M | Buy |
875,000
+10,000
| +1% | +$1.08M | 0.56% | 49 |
|
|
2024
Q1 | $82.1M | Hold |
865,000
| – | – | 0.43% | 61 |
|
|
2023
Q4 | $79.8M | Sell |
865,000
-175,000
| -17% | -$16.1M | 0.49% | 56 |
|
|
2023
Q3 | $52.2M | Buy |
1,040,000
+540,000
| +108% | +$27.1M | 0.39% | 75 |
|
|
2023
Q2 | $31.6M | Buy |
+500,000
| New | +$31.6M | 0.16% | 114 |
|
|
2022
Q1 | – | Sell |
-250,000
| Closed | -$26.8K | – | 461 |
|
|
2021
Q4 | $26.8K | Buy |
250,000
+150,000
| +150% | +$16.1K | 0.1% | 143 |
|
|
2021
Q3 | $10.3K | Buy |
+100,000
| New | +$10.3K | 0.04% | 226 |
|